Table 1.
Participant characteristics
| Participant characteristic | n (%) N = 39 |
|---|---|
| Age | |
| Mean | 46 years |
| Interquartile range | 42–52.5 years |
| Gender | |
| Men | 21 (53.8 %) |
| Women | 16 (41.0 %) |
| Transgender persons | 2 (5.1 %) |
| Race | |
| Indigenous | 23 (59.0 %) |
| Caucasian | 14 (35.9 %) |
| Other | 2 (5.1 %) |
| Drug use (30 days prior to interview)a | |
| Crack cocaine (smoked) | 22 (56.4 %) |
| Cocaine (injected) | 22 (56.4 %) |
| Heroin (injected) | 12 (30.8 %) |
| Crystal methamphetamine (injected or smoked) | 10 (25.6 %) |
| Years since ART diagnosis | |
| Mean (interquartile range) | 14.8 (10–19) |
| Years since ART initiation | |
| Mean (interquartile range) | 11.3 (6–16) |
| ART interruption events (≥30 days) since treatment initiation | |
| Mean (interquartile range) | 7.2 (5–9) |
a
Participants were able to select more than one response